Skip to content

Comparison of methods of cervical cancer screening

Comparison of Primary Human Papilloma Virus testing, Liquid based cytology and Co-testing for cervical cancer screening - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065698
Enrollment
500
Registered
2024-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: Nil: Nil

Sponsors

Sneha Arora
Lead Sponsor
Kamna Dutta
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Women more than 30 years of age

Exclusion criteria

Exclusion criteria: 1. Pregnant women 2. Women with history of cervical surgery 3. Women diagnosed with cervical cancer 4. HPV vaccinated women 5. Post hysterectomised women

Design outcomes

Primary

MeasureTime frame
Detection of pre-malignant and malignant lesions of cervixTimepoint: More than 30 years of age

Secondary

MeasureTime frame
Prevalence of HPV infection in Indian womenTimepoint: More than 30 years of age

Countries

India

Contacts

Public ContactKamna Datta

ABVIMS and Dr. RML hospital , Delhi

kamnadatta29@gmail.com9891145329

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026